Cardio Diagnostics Holdings annual return on equity
2022
2023
2024
2025
Cardio Diagnostics Holdings Return on Equity (ROE) Growth & History (CDIO)
Cardio Diagnostics Holdings's return on equity was −78.62% for fiscal 2025.
View full Cardio Diagnostics Holdings company overviewCardio Diagnostics Holdings annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −78.62% | +55.35 pp |
| 2024 | 2024-12-31 | −133.96% | +96.81 pp |
| 2023 | 2023-12-31 | −230.77% | −57.17 pp |
| 2022 | 2022-12-31 | −173.60% | — |
Cardio Diagnostics Holdings quarterly return on equity
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −18.39% | −2.44 pp |
| Q1 2026 | 2026-03-31 | −22.53% | −6.91 pp |
| Q4 2025 | 2025-12-31 | −19.38% | +3.57 pp |
| Q3 2025 | 2025-09-30 | −19.18% | +22.61 pp |
| Q2 2025 | 2025-06-30 | −15.95% | +26.20 pp |
| Q1 2025 | 2025-03-31 | −15.62% | +123.28 pp |
| Q4 2024 | 2024-12-31 | −22.94% | +30.01 pp |
| Q3 2024 | 2024-09-30 | −41.79% | +32.59 pp |
| Q2 2024 | 2024-06-30 | −42.15% | +84.94 pp |
| Q1 2024 | 2024-03-31 | −138.90% | −112.17 pp |
| Q4 2023 | 2023-12-31 | −52.95% | −18.67 pp |
| Q3 2023 | 2023-09-30 | −74.38% | −62.43 pp |
| Q2 2023 | 2023-06-30 | −127.09% | −111.03 pp |
| Q1 2023 | 2023-03-31 | −26.74% | +4.68 pp |
| Q4 2022 | 2022-12-31 | −34.28% | — |
| Q3 2022 | 2022-09-30 | −11.94% | — |
| Q2 2022 | 2022-06-30 | −16.07% | — |
| Q1 2022 | 2022-03-31 | −31.42% | — |
Cardio Diagnostics Holdings return on equity trends
Between the periods ended 2022-12-31 and 2025-12-31, Cardio Diagnostics Holdings's return on equity increased from −173.60% to −78.62%, a change of +94.98 percentage points. The latest reported quarter, Q2 2026, shows −18.39%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cardio Diagnostics Holdings source filings ↗